by ciidubai , 3 pages, 0 comment. Modified on .

SpeciGen is an early stage Biotech research a novel drug delivery system based on encapsulating drugs in nano particle protein cages. These can be targeted and "programed" to release where needed in the body. This presents a significant breakthrough in vaccines and cancer treatment.

Contents (hide)

1. Welcome to Specigen Corporation Ltd.
2. SpeciGen Enters Bio-Nanotechnology Agreement with Montana State University
3. NSF Current - October 2006
4. Comments

1. Welcome to Specigen Corporation Ltd.

   Home. Contact. Home | Management & Advisory Board. copyright © 2006 Specigen Inc. all rights reserved. ...

   http://www.specigen.com/

   1
2. SpeciGen Enters Bio-Nanotechnology Agreement with Montana State University

   SpeciGen has announced that they have signed an exclusive license agreement with ... license allows SpeciGen to initiate research, development and manufacturing ...

   http://www.azonano.com/news.asp?newsID=2230

   2
3. NSF Current - October 2006

   The researchers also established SpeciGen, a biotech company, which has ... SpeciGen has over $11 million in government funding. ...

   http://www.nsf.gov/news/newsletter/oct_06/index.jsp

   3

Most Viewed Notebooks
  (last 7 days)

Latest Notebooks

More notebooks...